Research Library

open-access-imgOpen AccessHuman Herpesviruses in Chronic Fatigue Syndrome
Author(s)
Howard L. Wallace,
Benjamin H. Natelson,
William C. Gause,
John Hay
Publication year1999
Publication title
clinical and diagnostic laboratory immunology
Resource typeJournals
PublisherAmerican Society for Microbiology
We have conducted a double-blind study to assess the possible involvement of the human herpesviruses (HHVs) HHV6, HHV7, Epstein-Barr virus (EBV), and cytomegalovirus in chronic fatigue syndrome (CFS) patients compared to age-, race-, and gender-matched controls. The CFS patient population was composed of rigorously screened civilian and Persian Gulf War veterans meeting the Centers for Disease Control and Prevention’s CFS case definition criteria. Healthy control civilian and veteran populations had no evidence of CFS or any other exclusionary medical or psychiatric condition. Patient peripheral blood mononuclear cells were analyzed by PCR for the presence of these HHVs. Using two-tailed Fisher’s exact test analyses, we were unable to ascertain any statistically significant differences between the CFS patient and control populations in terms of the detection of one or more of these viruses. This observation was upheld when the CFS populations were further stratified with regard to the presence or absence of major axis I psychopathology and patient self-reported gradual versus acute onset of disease. In tandem, we performed serological analyses of serum anti-EBV and anti-HHV6 antibody titers and found no significant differences between the CFS and control patients.
Subject(s)antibody , case control study , chronic fatigue syndrome , disease , environmental health , epstein–barr virus , immunology , medicine , population , psychiatry , psychopathology , serology , titer , virus
Language(s)English
eISSN1098-6588
pISSN1071-412X
DOI10.1128/cdli.6.2.216-223.1999

Seeing content that should not be on Zendy? Contact us.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here